Jeffrey C Moore

This inventor holds 74 USPTO granted patents and 21 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Biocatalyst Engineering (CPC class C12P). Top assignees: Codexis, Inc., Merck + Co., Inc., Merck Sharp & Dohme LLC. Active years: 1999-2026.

USPTO Granted Patents = 74 (Patent Applications = 21)

% Patents Active = 97.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 19)

Average Co-Inventor Count = 6.8

ph-index = 10

Forward Citations = 296(Granted Patents)

Forward Citations (Not Self Cited) = 75(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Fernley, NV (US) (1999)
Westfield, NY (US) (2014)
Westfield, NJ (US) (2006 - 2023)

Company Filing History:

Merck Sharp & Dohme LLC

Merck Sharp + Dohme Corp.

patents

6. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Biocatalysts

Imine Reductases

P450-BM3 Variants

Hydroxylation

Transaminase

Phosphopentomutase

Ketoreductase

Proline Hydroxylase

Nucleotides

Polynucleotides

Enzyme Variants

Chemical Compounds

74 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12709595 - NOVEL SYNTHETIC PATHWAY TO BELZUTIFAN (2026-08-18),

2. 12559514 - SYNTHESIS OF FLUORINATED NUCLEOTIDES (2026-02-24),

3. 12421532 - Polynucleotides encoding engineered imine reductases (2025-09-23),

4. 12421509 - Engineered phosphopentomutase variant enzymes (2025-09-23),

5. 12378533 - Engineered imine reductases and methods for the reductive amination of ketone and amine compounds (2025-08-05),

6. 12365882 - P450-BM3 variants with improved activity (2025-07-22),

7. 12344874 - Transaminase biocatalysts (2025-07-01),

8. 12312609 - Engineered imine reductases and methods for the reductive amination of ketone and amine compounds (2025-05-27),

9. 12286648 - Engineered proline hydroxylase biocatalysts for hydroxylation of chemical compounds (2025-04-29),

10. 12252723 - Ketoreductase polypeptides and polynucleotides (2025-03-18),

11. 12247234 - Biocatalysts and methods for hydroxylation of chemical compounds (2025-03-11),

12. 12110493 - Engineered purine nucleoside phosphorylase variant enzymes (2024-10-08),

13. 11807874 - P450-BM3 variants with improved activity (2023-11-07),

14. 11802274 - Engineered imine reductases and methods for the reductive amination of ketone and amine compounds (2023-10-31),

15. 11795445 - Engineered phosphopentomutase variant enzymes (2023-10-24),

Title: The Innovative Journey of Jeffrey C Moore

Introduction: Jeffrey C Moore, a talented inventor hailing from Westfield, NJ, has made significant contributions to the world of innovation with his groundbreaking ideas and inventions.

Latest Patents: Jeffrey C Moore's latest patents showcase his ingenuity and forward-thinking approach to problem-solving in various industries.

Career Highlights: Throughout his illustrious career, Jeffrey C Moore has been recognized for his exceptional creativity and dedication to pushing the boundaries of what is possible. His work has left a lasting impact on the field of inventions.

Collaborations: Jeffrey C Moore has collaborated with leading experts in the field, bringing together diverse perspectives to create truly innovative solutions to complex challenges. His collaborative spirit has been instrumental in his success as an inventor.

Conclusion: Jeffrey C Moore's passion for innovation and his relentless pursuit of excellence continue to inspire inventors and creators around the world. His legacy as a pioneering inventor is sure to endure for generations to come.